Industry landscapes
Industry report

Funding and advertised pay are reported in USD; filed accounts retain their stated source currency and basis.

Exchange-rate basis

Indicative conversions use ECB reference rates dated 2026-09-14, applied consistently across all periods. They are not historical exchange rates. Indian rupees may use crore (1 crore = 10 million); other currencies use K, M and B. CSV downloads, source documents and quoted news headlines retain their original currencies.

THE FRANCE EDITION 2026

France’s
life sciences industry,
in focus.

The companies, capital and talent shaping life sciences in France. Find the leaders. Understand the segments. See where the activity is.

Snapshot: Funding in USD
Illustrated cover for Life Sciences Industry Landscape of France
FR
COMPANIES · CAPITAL · TALENT

An industry ecosystem,
measured in context.

Life Sciences illustration
MEET THE COMPANIES

Explore France’s life sciences leaders

24 featured companies from the funding, hiring, revenue and team-size leaderboards.

Expand panel +
Life Sciences company highlights in France, snapshot 7 August 2026
Company
DBV Technologiesdbv-technologies.com$681M—88—
Valnevavalneva.com$441.04M—719Financial figure available in RadarView in Radar
Inventiva Pharmainventivapharma.com$433.2M—117$14.15MFYFY2024 filing
Genfitgenfit.com$424.76M—154Financial figure available in RadarView in Radar
Owkinowkin.com$355.62M—47$10.66MFYFY2020 filing
Abivaxabivax.com$319.6M—26—
DNA Scriptdnascript.com$309.32M—202$9.04MFYFY2024 filing
Amolyt Pharmaamolytpharma.com$292.31M—6—
Guerbetguerbet.com—9 roles520Financial figure available in RadarView in Radar
Septodontseptodont.com—9 roles500—
EA Pharmaea-pharma.com—8 roles215—
Nemeranemera.net—7 roles455—
Withingswithings.com—7 roles39$91.39MFYFY2022 filing
Ethypharmethypharm.com—6 roles1,500—
TISSIUMtissium.com—6 roles107—
UroMemsuromems.com—6 roles49—
AFYRENafyren.com——32—
Anthogyranthogyr.com——400—
BioSerenitybioserenity.com——340—
Cegedimcegedim.com——6,469$756.01MFYFY2024 filing
EDAP TMSedap-tms.com——264—
Fermentalgfermentalg.com——62—
Hemodiahemodia.com——400—
Nutrition & santenutritionetsante.com——924—
24 featured companies

Locked revenue figures are available in Radar; the eight company financial previews stay the same throughout this page. A dash means the figure is outside these featured lists. Revenue years vary by company; the figures are not a like-for-like revenue comparison. Compare annual accounts ↗

Company discovery

Recorded evidence only
THE KEY SIGNALS

Life Sciences industry KPIs in France

A few useful ratios bring the size of this ecosystem into perspective.

7 August 2026
Hiring participation8.8%

140 of 1,597 tracked companies have open roles.

Funding participation33.6%

536 of 1,597 tracked companies have a recorded round.

Top 3 funding share10.4%

Share of disclosed capital received by the three largest recorded recipients.

Median disclosed round$3.03M

Midpoint of 1,001 rounds with a disclosed amount.

Scale is concentrated. Opportunity is broader. The three largest funding recipients hold 10.4% of disclosed capital, while 66.4% of tracked companies have no recorded funding round.

Explore the segments →
CAPITAL & COMPANY FORMATION

How France life sciences has grown

Recorded company formation and disclosed funding across the complete annual series shown.

Expand panel +
2016 — 2025

Disclosed funding by year

Sum of recorded funding rounds · USD

France life sciences
$0$486.47M$972.93M$1.46B$1.95B2016: $735.12M20162017: $794.6M20172018: $887.33M20182019: $943.49M20192020: $924.1M20202021: $1.71B20212022: $1.52B20222023: $1.24B20232024: $1.19B20242025: $1.43B2025
View the numbers
Annual life sciences funding and company formation in France
YearFunding (USD)FoundedRaising
2016$735.12M7984
2017$794.6M7787
2018$887.33M6787
2019$943.49M70109
2020$924.1M7687
2021$1.71B5684
2022$1.52B3780
2023$1.24B2577
2024$1.19B1247
2025$1.43B252
WHERE CAPITAL SITS

Funding concentration

Share of all disclosed company funding.

  • DBV Technologies4.5%
  • Valneva2.9%
  • Inventiva Pharma2.9%
  • Other companies89.6%

Funding by stage

1,134 recorded rounds since 2016

NUMBER OF ROUNDS
Seed & Angel174 15.3%
Series A–B294 25.9%
Series C+ / PE70 6.2%
Grants, debt & other596 52.6%

Recent recorded rounds

Latest recorded rounds · USD
8 rounds

Swipe or scroll horizontally to browse.

Unattributed05/2026
Ennov —

Backed by Bregal Sagemount and Ardian.

Seed04/2026
SquareMind $18M

Backed by Sonder Capital and Bpifrance and others.

Grant (prize money)04/2026
AFYREN $3.51M

Backed by Just Transition Fund.

Grant (prize money)04/2026
CTIBiotech $1.47M

Backed by Bpifrance and Government of France.

Series B03/2026
Owkin $33M

Backed by OTB Ventures and AIC.

Series C03/2026
Waiv $33M

Backed by OTB Ventures and AIC and others.

Largest and notable recorded rounds

Each card is one recorded round
10 cards

Swipe or scroll horizontally to browse.

THE BUSINESS BEHIND THE ACTIVITY

Revenue, profitability & financial strength

Annual accounts for reporting companies linked to this landscape, on like-for-like currency and reporting bases.

Expand panel +
EUR · millions · standalone

Display conversions use the dated reference rates above. Where a verified rate is unavailable, figures retain their source currency. Each reporting cohort keeps its currency and accounting basis separate.

FY2024 · annual statements grouped by reported fiscal year; exact entity periods remain on preview rows · 10 reporting entities from 27 eligible matches.

Revenue in covered accounts€237.3m

Sum of reporting-entity revenue; not France market sales.

Net profit / loss€-1.2m

Combined result for the same cohort.

Aggregate net margin-0.5%

Combined net income ÷ combined revenue.

Median company revenue€5.7m

The middle covered reporting entity.

Profitable entities+30.0%

3 of 10 covered entities.

Top-five concentration+97.2%

Share of covered revenue from the five largest entities.

Annual account trend

Reported cohort totals by year; coverage is stated for every period.

Bar height shows revenue. Changes in coverage can affect totals.

Profitability has two perspectives

FY2024 · 10 reporting entities

Open the company accounts

Up to eight fixed company previews show financial amounts. Search and sort the wider company list, then continue in Radar.

10 reporting entities
Continue your financial research in Radar

Explore full company accounts and filings.

View financials in Radar ↗
FRANCE · INDUSTRY COHORTS

How does life sciences compare?

Each pair uses the same year, currency and reporting basis. Cohort overlap is disclosed.

IndustryCovered / eligibleRevenue totalMedian revenueNet profit / lossAggregate marginProfitable shareOverlap

Available-account cohorts are not estimates of whole industries. Overlapping entities can occur in more than one cohort; do not add cohort totals.

Coverage, calculations & financial sources

Filed annual accounts for exact designated national identifiers. Every aggregate and peer pair uses one fiscal year, source currency and reporting basis; periods, coverage and overlap are explicit; 2026 partials are excluded.

The same up to eight reporting entities remain open across years, filters and sorts. Other company figures are available in Radar.

Source currencies and accounting bases stay separate. Missing accounts are excluded rather than treated as zero. Exact reporting periods appear on company previews. Annual totals can change with coverage and do not measure growth of a fixed company cohort.

DIGITAL FOOTPRINT

Web traffic, app reach and release cadence

How the France companies on this page show up online: the sites people visit, the apps they install, and how often those apps ship.

Most-installed apps

61 of these companies (3.8%) publish at least one Android app — 102 apps in all, carrying 7.2M installs between them.

AppInstallsRatingStore category
WithingsWithings6M4.2Health & Fitness
Bluetens Get BetterBluetens321.5K4.3Health & Fitness
Emy - Kegel exercisesfizimed260.4K3.8Health & Fitness
COMME J\'AIMEcomme jaime142.5K—Health & Fitness
REMI - Baby monitor, Sleep TraUrbanHello77.4K1.6Parenting
CuureCuure64.3K—Health & Fitness
LifeazLifeaz38.6K—Education
actiTENSSublimed35.6K—Medical
myFibroScanEchoSens32K—Health & Fitness
Sefam Access LiteSEFAM28.5K—Medical

Installs are lifetime totals to date at the June 2026 store reading — a measure of reach, not of people using an app today.

App reach by segment

The busiest app inside each of this page’s own segments, with the quarterly release trend behind it (2023Q2–2026Q2).

SegmentAppsInstallsLeading appRelease trend
Wearable Technology176.1MWithings 6M
Disease Self Management166.1MREMI - Baby monitor, Sleep Tra 77.4K
Cardiac And Vascular Disorders76MLifeaz 38.6K
Pain Management3361KBluetens Get Better 321.5K
Pediatrics290.5KTucky 13.2K
Healthcare It3188.2KIDELab 26.9K
Nutraceuticals Tech482.2KCuure 64.3K
Life Sciences Tech2976.5KQR4Lab 14.8K

A company can carry several segment tags, so these rows overlap and should not be added together. Trend lines are zero-based and share one quarter grid, so a flat line is a quiet segment, not a missing one.

Release cadence by quarter

New apps published, beside apps whose most recent update landed in that quarter — the second bar is how much of the shelf is still being maintained.

2022Q4: 22022Q4: 12022Q42023Q1: 12023Q1: 02023Q12023Q2: 12023Q2: 12023Q22023Q3: 12023Q3: 32023Q32023Q4: 22023Q4: 32023Q42024Q1: 32024Q1: 02024Q12024Q2: 22024Q2: 22024Q22024Q3: 42024Q3: 62024Q32024Q4: 42024Q4: 12024Q42025Q1: 52025Q1: 22025Q12025Q4: 42025Q4: 102025Q42026Q1: 22026Q1: 162026Q1

Darker bars are new releases, lighter bars apps updated. 81 of 102 apps carry a release date. The series ends at 2026Q1, the last quarter that closed before the June 2026 reading.

INSIDE THE INDUSTRY

The France life sciences market map

Explore the segments behind the headline numbers.

Expand panel +

Where companies are building

Rank segments by scale, hiring or disclosed funding.

Enterprise tech1,023
Medical devices398
Biopharmaceuticals280
Healthtech224
Deep tech209
Enterprise software195
Consumer digital151
In vitro diagnostics73
Saas60
Healthtech saas46
Iot in healthcare43
Cancer immunotherapy40

Companies can sit in several segments. Counts and funding overlap.

SEGMENT TO EXPLORE

Enterprise tech

The largest measured segment in this report snapshot.

1023companies
9.9%have hiring activity

101 companies hiring · $13.75B disclosed funding

Explore in Radar

How companies make money

Common revenue models; a company can use more than one.

Physical commerce843
E-commerce - product650
Subscription447
Fee-for-service258
Commission on transaction24
Advertising12
E-commerce - service5
Sponsorship1
THE COMPANIES IN MOTION

Who is listing, hiring leaders, launching and winning work

Recorded corporate activity linked to companies in this landscape.

Expand panel +
Recent corporate headlines 10 dated reports
Mergers & acquisitionsstago.com ↗

La Caisse and health-care private equity firm Archimed Diagnostics have bought Stago, a French company specialized in the analysis of blood coagulation issues.

Mergers & acquisitionsrobocath.com ↗

Stereotaxis has acquired Robocath, a healthcare robotic assistance systems manufacturer, in a tech M&A deal valued at $20 million.

Funding roundsadocia.com ↗

Adocia (Euronext Paris: FR0011184241 ADOC, the "Company"), a clinical-stage biopharmaceutical Company focused on the research and development of innovative therapeutic solutions for the treatment of diabetes and obesity, today announced the establishment of a shareholder loan agreement with Vester Finance, repayable in new shares, with an option for the Company to repay in cash under certain conditions.

Mergers & acquisitionskamax-innovative.com ↗

the biggest acquisition in its history, taking over the entire capital of the German giant Kamax.

Funding roundsmayhealth.com ↗

Healthcare technology startup May Health, led by CEO and co-founder Dr. Robert Auerbach, secured $11.7 million in funding to accelerate development of its innovative treatment technology addressing infertility related to PCOS.

Mergers & acquisitionsbiomemory.com ↗

Biomemory has acquired selected assets from Catalog Technologies, a pioneer in DNA-based data storage and computing systems.

Mergers & acquisitionsabivax.com ↗

In January, French news outlet La Lettre reported that Eli Lilly was pursuing a potential €15 billion ($17.4 billion) Abivax acquisition

IPO activitycellectis.com ↗

Listing market: Euronext Growth ISIN code: FR0010425595 Date Total number of shares in the capital Total number of voting rights 02/28/2026 100,590,994 105,825,561

Funding roundsbiophytis.com ↗

Biophytis increases to €2 million the ceiling of its bond facility with Hexagon Capital Fund

Full recorded event mix

Top 10 categories among 841 recorded events in the 24-month window.

Earnings
223
Funding rounds
208
Leadership moves
109
Company announcements
70
Mergers & acquisitions
63
Contracts
48
Capital infusions
36
IPO activity
33
Regulatory
14
Board Updates
11
7 activity cards

Swipe or scroll horizontally to browse.

Leadership moves

21 tracked people moves

Thomas Gidoin

Appointment Deputy Managing Director

Marc Le Bozec

Appointment Managing Director

Aurore Morello

Appointment Scientific Director

Sensorion ↗
Amit Munshi

Appointment Acting Director General

Sensorion ↗
Nawal Ouzren

Resignation Previously Director General

Guerbet ↗
Jérôme Estampes

Resignation Group Chief Financial Officer and SVP Business Development & licensing

Guerbet ↗
Karim Boussebaa

Appointment Chief Executive Officer

BioSerenity ↗
Pierre-Yves Frouin

Departure Previously Founder and former CEO of BioSerenity

Product launches

Products, platforms and features in the recorded window

ennov ↗
Ennov 11.0

Unified GxP platform for life sciences

Workforce actions

1 companies with reported reductions

Polaris ↗

Scale not stated roles

Regulatory events

15 recorded events

Genfit ↗

accelerated approvalU.S. Food and Drug Administration (FDA)

Genfit ↗

registration filingAutorité des marches financiers (AMF)

pending approval of draft safeguard planParis Commercial Court

Advicenne ↗

Marketing approval received

Litigation

4 tracked suits

Company
ose immunotherapeutics v group of minority shareholders

shareholder rights disputeCivil · Dismissed

Company
kamax v FCA US

purchase order contract enforceability and price renegotiation disputeCivil · Verdict

Earnings pulse

Reported company results in the recorded window.

40companies
257period observations
7.1%median reported growth

Median across 125 reported growth observations; companies may contribute multiple periods.

Mergers and acquisitions

Company-linked deal reports; status is preserved as recorded.

Acquirer → targetStatusDateValue / context
caisse de depot et placement du quebec→Diagnostica Stago ↗Announced2026-04-29Not stated in snapshot
stereotaxis→Robocath ↗Announced2026-04-22$20.0M
fontana group→KAMAX Innovative System ↗Announced2026-04-14Not stated in snapshot
Biomemory→catalog technologiesAnnounced2026-03-11Not stated in snapshot
eli lilly→Abivax ↗Rumored2026-03-09$17.4B
Novacyt→southern crossAnnounced2026-02-23Not stated in snapshot

A discussion or rumour is not a completed transaction. An unstated value is not zero.

PEOPLE & OPPORTUNITY

The talent market

458 postings in the preceding 12 months. The full 1,153-posting snapshot covers 136 employers.

Expand panel +

Most advertised job titles

Conseiller En Pharmacie H/F50
Marketing Manager15
Attaché De Recherche Clinique/Attachée De Recherche Clinique9
Metteur En Service International8
Conducteur Conditionnement Pharmaceutique7
Corporate Distribution Quality System Manager6
0 internship postings

1 tracked postings mention remote work.

The seniority mix

157 postings specify a level.

unspecified
996
manager
71
senior
36
intern
33
entry
13
lead
4
ADVERTISED PAY$36.7K/ year

Median across 30 postings with pay data, expressed in USD.

THE PEOPLE BUILDING THE FIELD

Founders and leaders

1,106 founders and chief executives across 791 companies.

Expand panel +
12 profiles

Swipe or scroll horizontally to browse.

Education networks

99 profiles with education records.

HEC Paris
42
INSEAD
13
ESSEC Business School
10
Emlyon Business School
6
Massachusetts Institute of Technology
6
Université Grenoble Alpes
4
Imperial College London
4
University of Cambridge
3

Prior employers

6 profiles with prior-work records.

Google
3
Boston Consulting Group
2
McKinsey
1

Profiles cover recorded founders and leaders; contact details remain in Radar.

NEWS INTELLIGENCE

How this industry appears in the news

429,562 articles in the measured 12-month window.

Expand panel +
429,562articles in the measured year
71,943articles in 2026Q1
41.5%positive tone in the latest complete year

News volume trends

Life Sciences coverage across France · articles per complete quarter

063,978127,956191,934255,9122021Q2: 60,8542021Q22021Q3: 64,2092021Q4: 56,1622022Q1: 65,1322022Q2: 64,2352022Q22022Q3: 58,7682022Q4: 83,7322023Q1: 75,6912023Q2: 76,3042023Q22023Q3: 85,9492023Q4: 65,9622024Q1: 82,8522024Q2: 87,4142024Q22024Q3: 97,9722024Q4: 81,3262025Q1: 113,8232025Q2: 80,2792025Q22025Q3: 222,5322025Q4: 58,4052026Q1: 71,9432026Q1
View quarterly article counts
QuarterArticles
2021Q260,854
2021Q364,209
2021Q456,162
2022Q165,132
2022Q264,235
2022Q358,768
2022Q483,732
2023Q175,691
2023Q276,304
2023Q385,949
2023Q465,962
2024Q182,852
2024Q287,414
2024Q397,972
2024Q481,326
2025Q1113,823
2025Q280,279
2025Q3222,532
2025Q458,405
2026Q171,943

Article volume measures coverage, not market sales.

Tone of coverage over time

2021
114,518 positive · 8,654 neutral · 86,477 negative
2022
153,658 positive · 11,397 neutral · 106,309 negative
2023
183,251 positive · 10,654 neutral · 109,436 negative
2024
202,488 positive · 12,224 neutral · 134,092 negative
2025
196,977 positive · 11,946 neutral · 265,382 negative

Leading coverage topics

Life Sciences coverage across France · ranked by full-period article count.

International Political Relations72,763 articles in the full recorded period
17,033 recent · 14,317 prior
International Sports Competitions60,713 articles in the full recorded period
7,322 recent · 15,129 prior
Security And Defense Policies42,362 articles in the full recorded period
10,579 recent · 8,556 prior
Olympic Games Coverage32,395 articles in the full recorded period
3,506 recent · 11,276 prior
International Relations And Diplomacy31,218 articles in the full recorded period
7,770 recent · 6,287 prior
Nationalism And Sovereignty Debates22,274 articles in the full recorded period
4,037 recent · 4,231 prior
Professional League Updates21,057 articles in the full recorded period
3,304 recent · 3,470 prior
Championship Event Highlights19,790 articles in the full recorded period
2,941 recent · 4,030 prior
Government International Agreements Coordination16,931 articles in the full recorded period
3,566 recent · 3,109 prior
Athlete Transfer Rumors15,272 articles in the full recorded period
2,331 recent · 2,191 prior

Recent and prior counts use the source comparison windows.

Topics gaining and losing attention

Life Sciences coverage across France

KeywordRecentPriorChange
multilateral diplomacy1,8101,09465%
national security strategy94751385%
international cooperation73047454%
trade dispute mechanisms71246055%
bilateral trade58839848%
nuclear proliferation52227292%
study overseas42623383%
multilateralism40526453%
aerial bombardments40326652%
fire impact study402147173%
olympic team selections6103,297-81%
olympic trials5083,050-83%
olympic venues2361,776-87%
summer olympics athletics921,658-94%
olympians career highlights1181,429-92%

Event and signal lenses

Life Sciences coverage across France

All complete annual cohorts shown
Rising

Regulatory Risk

380,445 classified articles

inflation outlook, core inflation rate, inflation breakdown

47.8% critical · 29.4% positive
Rising

Funding Momentum

71,650 classified articles

club valuation, currency intervention policies, inflation reports fx

37.5% critical · 41.7% positive
Rising

Growth

157,603 classified articles

gdp growth rate, gdp acceleration, economic output growth

27.3% critical · 46.3% positive

Life Sciences coverage across France. Topic labels describe recorded classifications and can include broad context.

RESEARCH SIGNALS

What Life Sciences research is working on

53,147 papers in the recorded worldwide scope.

Expand panel +
53,147papers
53,147worldwide comparison pool
—India-affiliated papers

Research orientation

Descriptive
21,347
Promising
16,144
Breakthrough
7,516
Problem-identifying
4,407
Cautionary
1,880
Comparative
1,302
Critical
551

Contribution mix

Empirical
25,959
Reviews
19,786
Methods-led
5,939
Position pieces
1,146
Theoretical
317

Tone counts: 42,568 positive · 8,415 neutral · 2,164 negative.

Common problems researchers identify
4,958 papers · 9.3% of this field
  • Agriculture506 papers
  • Antibiotic resistance341 papers
  • Production233 papers
  • Human health225 papers
  • Sustainability221 papers
  • Antimicrobial216 papers
  • Food safety192 papers
  • Food security181 papers

Landmark: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term prob

Cautions
1,880 papers · 3.5% of this field
  • Agriculture96 papers
  • Food safety80 papers
  • Gene66 papers
  • Antibiotic resistance61 papers
  • Toxicity56 papers
  • Population55 papers
  • Production52 papers
  • Human health51 papers

Landmark: Genomic responses in mouse models poorly mimic human inflammatory diseases

Opportunities
23,660 papers · 44.5% of this field
  • Gene1,464 papers
  • Agriculture827 papers
  • Fermentation719 papers
  • Antimicrobial639 papers
  • In vivo588 papers
  • Population535 papers
  • Transcriptome527 papers
  • Downregulation and upregulation520 papers

Landmark: Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity

Leading institutions

Harvard University
86,693
Howard Hughes Medical Institute
74,901
Chinese Academy of Sciences
61,376
Centre National de la Recherche Scientifique
49,087
Cornell University
42,772
Stanford University
38,500

Leading researchers

Ahmad Almilaji
14,302
Reiki Nishimura
13,204
Tomofumi Osako
13,204
Yasuyuki Nishiyama
13,204
Rumiko Tashima
13,204
Masahiro Nakano
13,204
Glenn R. Gibson
12,830
Gregor Reid
10,793

Highly cited breakthrough-labelled papers

  • Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity9,015 citations
  • In situ click chemistry generation of cyclooxygenase-2 inhibitors7,514 citations
  • U1 snRNP regulates cancer cell migration and invasion in vitro7,224 citations
  • Comprehensive molecular profiling of lung adenocarcinoma5,754 citations
  • Lanthanum Chloride Inhibits LPS Mediated Expressions of Pro-Inflammatory Cytokines and Adhesion Molecules in HUVECs: Involvement of NF-κB-Jmjd3 Signal5,748 citations

Common problems researchers identify

4,503 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Sustainable Biofuel and Biomass ProductionCommon problems researchers identify · 01

Sustainable Biofuel and Biomass Production

781 papers

17.3% of this theme group

Researchers discuss challenges in using microbes and plant systems for renewable fuels and biorefinery processes.

Biofuel (41) · Synthetic biology (53) · Biomass (45) · Biorefinery (28)

A review on the plant microbiome: Ecology, functions, and emerging trends in microbial application

Biofertilizers: An ecofriendly technology for nutrient recycling and environmental sustainability

View research history
YearShare index
202260.4
202359.2
202462.0
202566.9
Food Safety and Processing RisksCommon problems researchers identify · 02

Food Safety and Processing Risks

757 papers

16.8% of this theme group

Papers highlight microbial hazards and nutritional impacts linked to food manufacturing and consumer health.

Food safety (130) · Food processing (74) · Food products (50) · Human health (90)

Microbial Risks in Food: Evaluation of Implementation of Food Safety Measures

Nutritional quality and processing of plant proteins for healthy and sustainable foods

View research history
YearShare index
202269.7
202371.2
202476.2
202598.4
Gene Expression and mRNA TherapeuticsCommon problems researchers identify · 03

Gene Expression and mRNA Therapeutics

711 papers

15.8% of this theme group

Studies examine cellular mechanisms, delivery methods, and regulatory concerns for RNA‑based interventions.

Messenger RNA (28) · Gene (44) · Cell culture (23) · Gene expression (24)

Analysis of Cancer Metabolism by Imaging Hyperpolarized Nuclei: Prospects for Translation to Clinical Research

Evolution of Approaches to the Development, Life Cycle Control, and Interchangeability of Veterinary Biosimilars Based on Hemoproteins (with

View research history
YearShare index
20222508.3
20232505.5
20242206.6
20251725.8
Crop Nutrition and Food SecurityCommon problems researchers identify · 04

Crop Nutrition and Food Security

693 papers

15.4% of this theme group

Research addresses fertilizer efficiency, nutrient uptake, and breeding strategies to sustain agricultural productivity.

Agriculture (208) · Crop (84) · Food security (86) · Germplasm (39)

Revisiting fertilisers and fertilisation strategies for improved nutrient uptake by plants

Breeding for nutrient use efficiency in crop plants: Mechanistic insights, genetic determinants, and emerging breeding technologies

View research history
YearShare index
20221631.9
20231660.6
20241795.2
20252000.4
Plant Disease Management StrategiesCommon problems researchers identify · 05

Plant Disease Management Strategies

691 papers

15.3% of this theme group

Works explore host immunity, pathogen interactions, and integrated pest control to reduce crop losses.

Fungicide (44) · Integrated pest management (54) · Host (41) · Disease management (32)

Innate Immunity in Plants: An Arms Race Between Pattern Recognition Receptors in Plants and Effectors in Microbial Pathogens

Insect-Borne Plant Pathogens and Their Vectors: Ecology, Evolution, and Complex Interactions

View research history
YearShare index
202227.7
202329.4
202427.9
202537.4
Antimicrobial Resistance Across SectorsCommon problems researchers identify · 06

Antimicrobial Resistance Across Sectors

447 papers

9.9% of this theme group

Analyses focus on the spread of drug‑resistant microbes in humans, animals, and the environment.

Antibiotic resistance (301) · Antimicrobial (164) · Antibiotics (126) · Drug resistance (49)

Antimicrobial resistance in humans, livestock and the wider environment

Antimicrobial use and resistance

View research history
YearShare index
2022882.3
2023835.4
2024912.9
2025968.7
Miscellaneous Biological and Chemical TopicsCommon problems researchers identify · 07

Miscellaneous Biological and Chemical Topics

423 papers

9.4% of this theme group

A diverse set of papers covering unrelated biochemical and sociological subjects.

Order (19) · NAD+ kinase (11) · Human being (12) · Sodium (11)

Modalidade, polaridade e legibilidade em resumos académicos: uma análise comparativa multidisciplinar

Obiteljska grupna konferencija: prilika za građansko pravosuđe?

View research history
YearShare index
202218.2
202321.4
202417.1
202512.4

Cautions

1,765 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Cellular Toxicity and Oxidative StressCautions · 01

Cellular Toxicity and Oxidative Stress

379 papers

21.5% of this theme group

Investigations assess how experimental conditions and contaminants affect cell viability and stress responses.

In vivo (32) · Flow cytometry (16) · In vitro (27) · Oxidative stress (19)

Effects of Microplastics on Cell Viability, Phagocytic Activity and Oxidative Stress in Human Peripheral Blood Mononuclear Cells

Cell Painting for cytotoxicity and mode-of-action analysis in primary human hepatocytes

View research history
YearShare index
20221032.2
20231112.2
2024911.3
2025828.7
Genomic Selection in Plant BreedingCautions · 02

Genomic Selection in Plant Breeding

257 papers

14.6% of this theme group

Authors discuss the promises and practical limits of using genomic data to improve crop traits.

Agriculture (45) · Selection (26) · Production (28) · Trait (16)

Genomic selection in plant breeding: from theory to practice

Future Directions for Sustainable Poultry Feeding and Product Quality: Alternatives from Insects, Algae and Agro-Industrial Fermented By-Pro

View research history
YearShare index
20221433.4
20231471.3
20241631.9
20251793.7
Feed Additives and Animal HealthCautions · 03

Feed Additives and Animal Health

245 papers

13.9% of this theme group

Research evaluates the efficacy and safety of natural compounds used to enhance livestock nutrition.

Feed additive (27) · Animal feed (28) · Feed conversion ratio (32) · Health benefits (30)

Natural Bioactive Compounds as Feed Additives: Strategies for Sustainable and Functional Livestock Production

The impact of substituting animal with plant protein foods in adults’ self-selected diets on environmental, nutritional, and health outcomes

View research history
YearShare index
202221.2
202319.9
202417.3
202517.6
Food Contaminants and Regulatory IssuesCautions · 04

Food Contaminants and Regulatory Issues

240 papers

13.6% of this theme group

Papers review safety concerns and policy considerations for emerging food additives and contaminants.

Food safety (66) · Hygiene (21) · Contamination (29) · Food contaminant (20)

Caffeine (1, 3, 7‐trimethylxanthine) in Foods: A Comprehensive Review on Consumption, Functionality, Safety, and Regulatory Matters

Insect-derived food colorants: Chemistry, applications, safety, and regulatory perspectives

View research history
YearShare index
202292.1
202389.1
202494.2
2025105.4
DNA Damage and Repair MechanismsCautions · 05

DNA Damage and Repair Mechanisms

239 papers

13.5% of this theme group

Studies investigate how genomic instability influences disease and the challenges of accurate measurement.

Gene (41) · DNA damage (26) · DNA repair (13) · Gene expression (20)

Comparative analysis of microRNA expression in serum and plasma in patients screened for BRCA1 or BRCA2 mutations

Homologous recombination deficiency in primary ER-positive and HER2-negative breast cancer

View research history
YearShare index
20222414.1
20232426.1
20242133.7
20251642.1
Antibiotic Use and Co‑Selection PressuresCautions · 06

Antibiotic Use and Co‑Selection Pressures

206 papers

11.7% of this theme group

Works highlight how antimicrobial practices can promote resistance alongside other environmental stressors.

Antibiotic resistance (59) · Antibiotics (47) · Antimicrobial (38) · Bacteria (26)

Antibiotic use in food animals worldwide, with a focus on Africa: Pluses and minuses

Co-Selection of Resistance to Antibiotics, Biocides and Heavy Metals, and Its Relevance to Foodborne Pathogens

View research history
YearShare index
2022882.3
2023835.4
2024912.9
2025968.7
Pesticide Resistance and ManagementCautions · 07

Pesticide Resistance and Management

199 papers

11.3% of this theme group

Research examines biological control options and dosing strategies to mitigate evolving pesticide tolerance.

Pesticide (34) · Integrated pest management (21) · PEST analysis (30) · Biological pest control (20)

The use of fungal entomopathogens as endophytes in biological control: a review

Managing pesticide resistance by changing the applied dose: a modeling analysis incorporating pesticide persistence and including low-dose m

View research history
YearShare index
202266.0
202365.3
202466.9
202576.7

Opportunities

22,038 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Advanced Antibody and Imaging TechniquesOpportunities · 01

Advanced Antibody and Imaging Techniques

1,044 papers

17.4% of this theme group

Innovations in fluorescent labeling and flow analysis expand capabilities for in‑vivo diagnostics.

Antibody (70) · In vivo (81) · Fluorescence (40) · Flow cytometry (50)

Figure 4 from Ancestrally Diverse Autologous Patient-Derived Organoid–Immune Cell Coculture Platform for Addressing Immunotherapeutic Outcom

Preparation, Characterization, and Binding Mechanism of Nanobodies Targeting Multiple Serotypes of <i>Salmonella</i>

View research history
YearShare index
2022560.8
2023617.6
2024466.3
2025459.8
Gene Regulation for Disease TherapyOpportunities · 02

Gene Regulation for Disease Therapy

1,032 papers

17.2% of this theme group

Explorations of knockdown and modulation approaches aim to control cell growth and apoptosis.

Downregulation and upregulation (106) · Apoptosis (80) · Gene knockdown (103) · Cell growth (43)

Fat Mass and Obesity‐Associated Protein Contributes to Tumorigenesis and Drug Resistance of Diffuse Large B‐Cell Lymphoma by Suppressing <sc

RasGRP3 Promotes RAP1B Activity to Inhibit Endothelial Inflammation and Alleviate Atherosclerosis in High-Fat Diet-Fed ApoE−/− Mice

View research history
YearShare index
2022362.8
2023394.7
2024255.9
2025266.9
Functional Plant‑Based FoodsOpportunities · 03

Functional Plant‑Based Foods

878 papers

14.6% of this theme group

Papers describe bioactive ingredients that support health and promote sustainable nutrition.

Health benefits (78) · Functional food (61) · Ingredient (48) · Antioxidant (69)

Plant-based functional foods for healthy aging: current trends, bioactive compounds, and future perspectives

PLANT-BASED PROTEINS: SOURCES, EXTRACTION METHODS AND FUNCTIONAL PERSPECTIVES FOR THE SUSTAINABLE FOOD INDUSTRY

View research history
YearShare index
202226.7
202325.8
202427.4
202544.8
Epigenetic Editing and DetectionOpportunities · 04

Epigenetic Editing and Detection

823 papers

13.7% of this theme group

Research focuses on DNA methylation tools and sensitive assays for disease‑related RNA markers.

Gene (164) · DNA methylation (60) · Messenger RNA (76) · DNA damage (55)

Convergent DNA methylation abnormalities at enhancers and bivalent promoters in human growth disorders

Stimuli-ResponsiveFusion of Binary-Star IntelligentDNA System for the Signal-On Amplification Detection of Cancer-RelatedmiRNA

View research history
YearShare index
20222396.5
20232385.8
20242123.6
20251641.4
Novel Antimicrobials and BiocontrolOpportunities · 05

Novel Antimicrobials and Biocontrol

809 papers

13.5% of this theme group

Studies identify plant‑derived compounds and postbiotic products to combat resistant microbes.

Antimicrobial (126) · Antibiotic resistance (66) · Biological pest control (54) · Bacteria (87)

Plants as sources of new antimicrobials and resistance-modifying agents

Postbiotics: Multifunctional Microbial Products Transforming Animal Health and Performance

View research history
YearShare index
2022524.8
2023510.2
2024556.9
2025654.9
Genetic Improvement of Crop TraitsOpportunities · 06

Genetic Improvement of Crop Traits

717 papers

11.9% of this theme group

Investigations use quantitative trait loci and selection methods to boost yield and quality.

Germplasm (71) · Trait (52) · Quantitative trait locus (40) · Selection (53)

Evaluation of Genetic Variability and Trait Interrelationships Using Advanced Wheat Lines to Increase Yield

GENETIC VARIABILITY ANALYSIS FOR YIELD AND RELATED TRAITS IN WHEAT (TRITICUM AESTIVUM L.) MUTANT GENOTYPES

View research history
YearShare index
202252.7
202345.3
202439.3
202541.1
Sustainable Biomass and Biofuel InnovationsOpportunities · 07

Sustainable Biomass and Biofuel Innovations

697 papers

11.6% of this theme group

Research explores microbial fermentation and by‑product valorization for greener agriculture and energy.

Biomass (67) · Sustainability (77) · Agriculture (102) · Biofuel (35)

Microbial Fermentation: A Sustainable Strategy for Producing High-Value Bioactive Compounds for Agriculture, Animal Feed, and Human Health

Bioactive Compounds From Agri‐Food By‐Products: Advancements in Environmental Sustainability and Bioeconomic Progress

View research history
YearShare index
20221511.1
20231558.6
20241735.8
20251952.4

How this field compares with the research baseline

Orientation shares compared with 25,000 papers in the reference sample.

Research orientationThis fieldReference sample
Descriptive40.2%17.4%
Promising30.4%36.8%
Breakthrough14.1%26.1%
Problem-identifying8.3%10.1%
Cautionary3.5%4.6%
Comparative2.4%4.0%
Critical1.0%0.9%

Concerns receiving less research attention

Counts and shares refer to the stated research pool. A low count describes how much of that research is recorded here, not the absence of a real-world concern.

Concern / example paperPapersShareRaised as a problemWorldwide share
Privacy & surveillanceSARS-CoV-2 wastewater genomic surveillance: approaches, challenges, and opportunities870.21%25 (28.7%)0.21%
Hardware, e-waste & supply chainFate and Transport of Antibiotic Residues and Antibiotic Resistance Genes following Land Application of Manure Waste610.15%4 (6.6%)0.15%
Bias & fairnessGeographic Prevalence Heterogeneity Creates Unavoidable Fairness-Accuracy Trade-offs in Antimicrobial Resistance Predict120.03%2 (16.7%)0.03%
Safety & misusePublic perceptions and information sources on genetically modified organisms in Kenya30.01%3 (100.0%)0.01%
Energy & datacenter footprintIntegration of GWAS and WGCNA Identifies PUE‐Related Gene <i>TaERF112</i> in Wheat10.0%0 (0.0%)0.0%
Water use00.0%0 (%)0.0%
Carbon & emissions of compute00.0%0 (%)0.0%
Labour & data work00.0%0 (%)0.0%
Concentration of compute power00.0%0 (%)0.0%

Research orientation and citation rankings describe the covered collection. Its recorded publication dates do not support an overall publication-volume trend.

Institution and researcher rankings use citations to their covered work. Research scope: worldwide. This may be broader than the company geography.

GEOGRAPHIC FOOTPRINT

Where companies are based

Company counts, hiring and disclosed funding across the recorded hubs.

Expand panel +
8 cards

Swipe or scroll horizontally to browse.

UNDERSTAND THE LANDSCAPE

Life Sciences in France: key questions

Clear definitions for making better comparisons.

What does this landscape measure?

It measures the tracked company ecosystem, recorded funding, hiring and other available evidence. It is not a market-size estimate.

Can segment counts be added together?

No. A company can belong to several segments, so segment counts and funding can overlap.

What does a missing figure mean?

A dash or unavailable panel means the current reviewed source snapshot does not support that figure.

Company ecosystem snapshot: 7 August 2026. Funding is recorded in USD; filed accounts retain their stated currency and reporting basis. Each section identifies its own coverage. The news and research behind these sections is explorable in Prism.

Canonical landscape ↗
Coming soon